Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76929 | 0.92 | MAPT (0.33) | NQO2MAPTKDM4EALDH1A1LMNA | |
| SCHEMBL812478 | 0.88 | NQO2 (0.35) | NQO2MAPTKDM4EALDH1A1LMNA | |
| SCHEMBL3874742 | 0.88 | MAPT (0.38) | NQO2MAPTKDM4EALDH1A1LMNA | |
| SCHEMBL26826367 | 0.85 | IDO1 (0.32) | ALDH1A1 | |
| SCHEMBL78377 | 0.74 | IDO1 (0.32) | — | |
| SCHEMBL768983 | 0.72 | MEN1 (0.31) | MAPT | |
| SCHEMBL15339507 | 0.70 | HTT (0.37) | NQO2MAPTKDM4EALDH1A1 | |
| SCHEMBL16501144 | 0.70 | ADORA2A (0.31) | MAPTALDH1A1 | |
| SCHEMBL13840466 | 0.70 | KCNJ1 (0.33) | — | |
| SCHEMBL26194074 | 0.69 | MAPT (0.33) | NQO2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180141933-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141933-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, NR2E3, ERG | NQO2 2761/4885MAPT 811/4885KDM4E 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.